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Abstract Regulators of G-protein signalling (RGS) are recently
identified proteins that shorten the lifetime of the activated G
protein. We now show that rat cardiac myocytes express mRNA
for at least 10 RGS. The mRNA for RGS-r is barely detectable
in rat ventricles, but increases more than 20-fold during the 60- to
90-min process of isolating ventricular myocytes, and after
90 min of culture of atrial pieces in medium with Ca2+. Both in
myocytes and in atria, the rise in RGS-r is transient. The mRNA
for cardiac RGS5, but not RGS-r, is developmentally regulated.
These studies suggest that rapid regulation of RGS levels may be
a new mechanism that governs how signals are transmitted across
the cardiac cell membrane.
z 1998 Federation of European Biochemical Societies.
Key words: RGS protein; G protein; Heart; Cardiocyte;
mRNA expression
1. Introduction
Signals that control cellular responses are transmitted
across the plasma membrane by an information relay system
that involves speci¢c receptors, a set of coupling proteins
(called G proteins because they bind GTP), and intracellular
e¡ectors. Over the last few years, it has become clear that
additional components can modulate the function of the
transmembrane signalling system by acting on the G proteins
[1,2]. The RGS proteins bind to the GK (GTP-binding) sub-
unit of the G proteins and, among other actions, increase the
rate of GTP hydrolysis. By this and other mechanisms, RGS
proteins increase the rate at which G-protein-mediated signals
are turned o¡ [3].
Many studies have shown that G-protein levels change
rather little with changing physiological conditions. For exam-
ple, in various cardiac diseases, G-protein levels rise and fall
usually by a factor of 2, but not by an order of magnitude [4].
Similarly, as PC12 cells develop, the levels of G proteins do
change, but rather modestly [5]. When changes in G-protein
levels do occur, they tend to occur slowly. In contrast, the ¢rst
RGS protein discovered, the yeast Sst2 protein, is strongly
induced by yeast pheromone within 60 min [6]. Similarly,
treatment of B lymphocytes with mitogen or an activator of
protein kinase C for 24 h induces expression of RGS1 mRNA
[7]. The ability of RGS proteins to be rapidly regulated in-
troduces a potentially important new element in understand-
ing the mechanisms by which cells control their responses to
changing external and internal environments.
So far, over 20 RGS proteins have been described [8]. Since
it is apparent that the RGS family of proteins is very large,
the question of speci¢city becomes extremely important. RGS
proteins can bind to and increase the GTPase activity of many
G proteins in the GKi and/or GKq classes, but none in the GKs
class [9^11]. The potential for crosstalk among di¡erent RGS
proteins would not be of any biological relevance if each RGS
protein occurred in a di¡erent cell type. But if cells contain
many di¡erent RGS, then what determines which G protein is
regulated and when? The distribution of RGS proteins has
been analyzed across many tissue types, but so far, there
has been no report of the number of di¡erent RGS proteins
that occur within a single cell type. The cell must control the
function of each of its RGS proteins to allow any signal to
move speci¢cally and with the right duration through the G-
protein network. In this manuscript, we report that cardiac
myocytes express mRNA for at least 10 di¡erent RGS pro-
teins. The mRNA for one of these, RGS-r, is rapidly and
markedly elevated in the process of isolating myocytes from
rat ventricles or in cultured atria. RGS mRNA levels also
change in culture and in development. These studies reveal
the complexity and dynamic regulation of the RGS regulatory
system in cardiac myocytes.
2. Materials and methods
2.1. RT-PCR and generation of RGS probes
Reverse transcription (RT) was carried out using the Superscript
preamplication system according to the manufacturer’s instructions
(Gibco-BRL). For PCR ampli¢cation, a pair of degenerate primers
spanning the RGS core domain were used: Forward ^ G(G/
A)IGA(G/A)AA(T/C)(A/T/C)TIGA(G/A)TT(T/C)TGG; Reverse ^
G(G/A)TAIGA(G/A)T(T/C)ITT(T/C)TT(T/C)CAT. PCR products
of the expected size were cloned into a TA-cloning vector pCR2.1
(Invitrogen). By using this approach, we cloned RGS 3, 4, 5 and r.
To clone other RGS members, speci¢c PCR primers were designed,
based on their published nucleotide sequences [12,13]. All positive
clones were veri¢ed by sequencing. Plasmid DNA containing each
RGS insert was digested with appropriate restriction enzyme(s) to
release the insert for use as a probe in Northern blot.
2.2. Myocyte and atrial preparation
Myocytes were isolated from adult rat ventricles as described pre-
viously, and cultured in DMEM supplemented with albumin, carni-
tine, creatine, insulin, taurine and triiodothyronine (ACCITT) [14].
Rats (150^200 g) were sacri¢ced by CO2 inhalation for 3 min by
procedures that meet institutional guidelines. The left and right atria
were cut into half and placed in 24-well plates containing Ca2-free
DMEM (Gibco-BRL), plus 1 mM Ca2 or 5 mM EGTA. Each half
atrium was further chopped into small pieces and incubated in a 37‡C
incubator with 6% CO2 for di¡erent times. At the end of each time
point, atrial pieces, together with the medium, were transferred into
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2.0-ml tubes, centrifuged for 2 min and liquid was removed. The atrial
pieces were frozen in dry ice for RNA preparation.
2.3. RNA preparation and Northern blot analysis
Total RNA was isolated from rat atria, ventricles, brain and car-
diomyocytes using RNAzol according to the manufacturer’s instruc-
tions (Tel-Test, TX, USA). For myocytes, RNAzol was added directly
to the 100-mm dishes after the culture medium was removed. Ten Wg
of total RNA were loaded on a formaldehyde-containing gel, blotted
onto a nylon membrane and hybridized with 32P-labelled RGS probe
[15]. The membrane was re-probed with 32P-end-labeled 24-mer oli-
gonucleotide speci¢c for rat 18S rRNA (5P-ACGGTATCT-
GATCGTCTTCGAACC-3P) [16]. The bands were scanned by Desk-
Scan II program and analyzed by NIH Image Program. The amount
of RGS mRNA was normalized to 18S rRNA.
3. Results
3.1. Ventricular myocytes express mRNA for 10 di¡erent RGS
proteins
We used two RT-PCR based approaches to determine the
expression of RGS proteins in the heart and to develop a set
of probes for Northern blot analysis, as described in Section
2. The ¢rst was to use degenerate primers to identify known
and, potentially, novel RGS proteins. The second was to use
oligonucleotides speci¢c for known RGS sequences. To pre-
pare probes, RT-PCR was carried out using heart and brain
mRNA. For analysis of the complement of mRNA for RGS
proteins in the heart, we analyzed mRNA from whole ven-
tricles and isolated cardiomyocytes. In cardiomyocytes, the
transcripts for some RGS (RGS1, RGS3, RGS4, RGS5,
RGS6 and RGS-r) were relatively abundant and could be
detected by both RT-PCR and Northern blot (Fig. 1A; RT-
PCR data not shown), others (RGS7, RGS9, RGS12 and
RGS14) were less abundant and could only be detected by
RT-PCR but not by Northern blot (Fig. 1B and Northern
blot, data not shown). RGS8 was undetectable even by RT-
PCR, while RGS10 and RGS11 gave faint bands that were
not clearly interpretable (data not shown). Thus, the cardio-
myocyte expresses mRNA for at least 10 di¡erent RGS pro-
teins.
The levels of mRNA for RGS4, 5, 6 (Fig. 1A) and 3 (data
not shown) were similar in whole ventricles and in cardiomyo-
cytes. RGS1 mRNA was slightly higher in cardiomyocytes
than in intact ventricle but the overall expression level was
so low that we did not investigate it further. We conclude that
these RGS mRNAs are found both in ventricular myocytes
and in non-myocyte cells.
3.2. RGS-r mRNA increases rapidly in isolated ventricular
myocytes and cultured atria
In contrast to RGS1, 3, 4, 5 and 6, the expression of RGS-r
was dramatically di¡erent between the intact ventricle and the
isolated cardiomyocyte (Figs. 1A and 2). Analysis of 8 inde-
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Fig. 1. RGS mRNA expression in rat ventricles and cardiomyo-
cytes. Ten Wg of total RNA isolated from rat ventricles and isolated
cardiomyocytes was used for Northern blots as described in Section
2. Panel A shows autoradiograms of the Northern blots for the six
RGS mRNAs we could detect by this method. Washing conditions
for RGS 1, 3, 4 and 6 are: 2USSC (1USSC = 0.15 M NaCl,
0.015 M sodium citrate, pH 7.0), 0.1% SDS at room temperature
for 20 min; 0.25USSC, 0.1% SDS at 60‡C for 15 min, twice. For
RGS5 and RGS-r, an additional wash (0.1USSC, 0.1% SDS at
60‡C for 10 min) was included. The transcript sizes for RGS1, 3, 4,
5, 6 and r are 1.6 kb, 4.1 kb, 3.3 kb, 4.4 kb, 3.1 kb and 2.5 kb, re-
spectively. Some RGS that were negative by Northern blots could
be detected by RT-PCR (panel B). The expected product sizes for
RGS7, RGS9, RGS12 and RGS14 (184, 159, 602 and 666 bp, re-
spectively) are indicated by arrows.
Fig. 2. Comparison of RGS-r expression in rat ventricle and in
freshly prepared myocytes. RNAs from adult rat ventricle and
freshly-made ventricular myocytes were analyzed in parallel by
Northern hybridization with the rat RGS-r probe (core domain,
241 bp) and reprobed with rat 18S rRNA (see Section 2). The ¢lms
were scanned, analyzed by NIH Image Program, and each lane nor-
malized to 18S rRNA. The normalized amount of RGS-r mRNA in
freshly frozen ventricle was set as 1. Data shown represent means
þ S.E.M. of 3 independent preparations of ventricular mRNA and
8 independent preparations of myocyte mRNA analyzed on one
membrane. The same ratio of mRNA in ventricle to myocytes was
seen in 8 other experiments each analyzed separately.
T. Kardestuncer et al./FEBS Letters 438 (1998) 285^288286
pendent preparations of cardiomyocytes showed that the
mRNA for RGS-r was 22 þ 2-fold higher in freshly prepared
myocytes than in whole ventricle (Fig. 2). The increase cannot
be due simply to puri¢cation of myocytes because myocytes
make up about 20^30% of cells in the ventricle so puri¢cation
could only account for a 3- to 5-fold increase. The 60- to 90-
min procedure for making myocytes from ventricles involves
hanging the hearts and perfusing them with a mixture of
enzymes to dissociate the cells, followed by centrifugation
and di¡erential plating, as described in Section 2. We meas-
ured the mRNA for RGS-r at each step of myocyte prepara-
tion and found that the rise in RGS-r mRNA occurs when the
Ca2 concentration is increased to 1.0 mM. In the absence of
Ca2, collagenase alone or treatment with trypsin and DNase
increase RGS-r slightly, but far less than the level seen in the
full myocyte preparation (data not shown).
To de¢ne further the factors that regulate RGS-r mRNA in
the heart, we tried to make myocytes without increasing
RGS-r mRNA but were unsuccessful, as we were unable to
obtain signi¢cant yields of dissociated myocytes in Ca2-free
medium. Therefore, to de¢ne Ca2 dependence of RGS-r
mRNA expression, we used atria in organ culture. Atrial
pieces can be kept in culture for several hours and are suitable
for study of agonist stimulated enzyme activities such as
PLCL [17]. Left and right atrial pieces were always incubated
separately, but the time course and magnitude of RGS-r ex-
pression was similar in both. As shown in Fig. 3, the RGS-r
transcript was very low in rat atria frozen immediately after
collection, but began to rise after 60 min of culture in DMEM
with 1 mM Ca2. By 120 min, the mRNA for RGS-r in-
creased approximately 90-fold over the initial level, then de-
clined. In Ca2-free medium (DMEM with 5 mM EGTA),
RGS-r mRNA also rose, but more slowly reaching a level
only 20% of that with Ca2. Thus, there seem to be both
Ca2-dependent and -independent steps regulating RGS-r ex-
pression.
We were unable to cause elevation of RGS-r mRNA by
isoproterenol (10 WM), carbachol (1 WM) or endothelin (0.1
WM) either in media containing or lacking Ca2 (data not
shown). Recently, Buckbinder et al. [18] showed that expres-
sion of RGS-r (that they called ‘A28-RGS14’) can be induced
in a human carcinoma cell line by the p53 tumor suppressor
or by doxorubicin. Doxorubicin is a potent anti-tumor drug
whose clinical value is limited because it causes cardiomyo-
pathy. However, 16 h of culture with 1 WM doxorubicin does
not elevate RGS-r in the atria (data not shown), so it is un-
likely that this mechanism contributes to doxorubicin cardiac
toxicity.
3.3. RGS content changes on extended culture of
cardiomyocytes
Although RGS-r mRNA increased sharply when cardiac
myocytes are isolated, it decreased by about 70% within 8 h
of culture in Ca2-containing DMEM supplemented with AC-
CITT (Fig. 4A). However, even after 32 h, the level was high-
er than in the freshly frozen ventricle. Similarly, in cultured
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Fig. 3. RGS-r mRNA increases upon culture of rat atria. Rat atria
were cut into half and incubated in DMEM with 1 mM Ca2 or
5 mM EGTA at 37‡C. At each time point, atrial pieces were col-
lected and frozen on dry ice. Total RNAs were then isolated simul-
taneously and analyzed for RGS-r mRNA by Northern blot. The
amount of RGS-r mRNA was normalized to 18S RNA. The
amount of RGS-r mRNA in atria frozen immediately after removal
from the animal was set as 1. Left atria and right atria were ana-
lyzed separately and gave similar results. The ¢gure shows a repre-
sentative experiment from right atria. Similar results were obtained
in 3 independent experiments analyzing both right and left atria.
Fig. 4. RGS expression decreases upon culture of ventricular myo-
cyte cells. A: Total mRNA was isolated from adult rat ventricle,
neonatal rat ventricle (2-day old), and adult ventricular myocytes in-
cubated in DMEM medium for the time period indicated. The
RNAs were analyzed by Northern hybridization with RGS-r probe
(core domain, 241 bp) and reprobed with 18S rRNA oligonucleo-
tide. The band densities were quantitated by the NIH Image Pro-
gram and normalized to 18S rRNA. The amount of RGS-r mRNA
in adult ventricle was set as 1. The experiment shown is representa-
tive of two similar ones. B: The same membrane as was shown in
A was re-analyzed using the RGS5 probe (core domain, 241 bp).
The data were analyzed as described in A. Similar results were seen
in 2 additional independent experiments.
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atria, RGS-r expression began to decline after 2 h (Fig. 3).
The decline in RGS-r mRNA is not unique because RGS5
also declined in culture, although with a di¡erent time course
and disappeared almost completely within 32 h (Fig. 4B).
Note that RGS5 mRNA is developmentally regulated since
it is about 5-fold higher in adult ventricle than in neonatal
ventricle. There is no striking di¡erence in RGS-r mRNA
between neonatal and adult ventricles, but the levels in both
are extremely low.
4. Discussion
The cardiomyocyte contains at least 9 di¡erent GK sub-
units, with members representing each of the four families
of GK subunits (GKi, GKq, GKs, GK12) [19,20]. GK12 is found
in heart, but it is not known whether it occurs in cardiac
myocytes. The RGS proteins characterized so far activate
members of the GKi and GKq families. Cardiomyocytes
have at least 6 isoforms of these RGS-sensitive G proteins
(GKo, GKi2, GKi3, GKq, GK11, GKz). We now show that ven-
tricular myocytes express mRNA for at least 10 di¡erent RGS
proteins. Because antibodies for all these RGS proteins are
not yet available, we cannot know for the whole set how
mRNA abundance relates to protein abundance. Potentially,
cardiac myocytes could contain as many (or more) di¡erent
types of RGS proteins as they have target GK subunits. This
observation suggests that di¡erent RGS proteins may be
called into play under di¡erent physiological circumstances.
Our data show that mRNA for at least one RGS protein in
the heart, RGS-r, is dramatically increased in the process of
isolating myocytes from intact ventricle. This observation
shows that it is very di⁄cult to know exactly what the full
complement of RGS proteins in any cell actually is. For ex-
ample, some of the RGS proteins that we were not able to
detect in the heart or detect only by RT-PCR may, in fact, be
abundantly expressed under the correct physiological condi-
tion which we did not happen to replicate in the course of our
experiments. Therefore, the example of RGS-r tells us that
what we have found is a minimum number, but not necessar-
ily the total complement of RGS mRNAs that cardiocytes are
capable of expressing.
Isolated ventricular myocytes are used as a model of my-
ocyte function in an intact ventricle. We now show that the
very process of creating myocytes dramatically changes the
mRNA for at least one RGS protein. While it is well known
that changes in mRNA levels are not always accompanied by
an equivalent rise in protein, it would be extremely unusual
for such a dramatic increase in mRNA not to be accompanied
by a substantial increase in cellular protein levels. Develop-
ment of anti-RGS-r antibodies will eventually allow us to
determine the extent to which the rise in RGS-r mRNA is
re£ected by a rise in protein. In the atrial pieces, we showed
that there is both a Ca2-dependent and a Ca2-independent
process that leads to the elevation of RGS-r mRNA.
These studies illustrate the complex regulation of cardiac
signal transduction systems. Changing levels of RGS proteins
in cultured cells are likely to be re£ected in altered agonist
sensitivity of some receptors. Our studies reemphasize the dy-
namic character of signal transduction systems in cardiac my-
ocytes and suggest that rapid regulation of RGS levels may be
a new regulatory mechanism that governs how signals are
transmitted across the cardiac cell membrane.
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